Immunotherapy with IgY is by design a low toxicity treatment and is therefore ideally suited for long term prophylaxis, even more so for conditions where it is simply not possible to stay away from the microorganisms that cause the infection.
This is exactly the situation for cystic fibrosis patients.
IMMUNSYSTEM's drug candidate, Anti-Pseudomonas IgY, is a daily
treatment to help in the battle against the daily dose of
bacteria that none of us can escape.
Protein A ELISA
Our Protein A ELISA is
specific, highly sensitive and designed to detect protein A
contamination in samples with high amount of antibodies.
MouSelect Protein A binding test
Purification on Protein A is the most common method for purification of antibodies, especially
in the later phases of pharmaceutical development. The MouSelect kit are designed to aid in
an early selection of polyclonal or monoclonal antibodies, to a preferential purification on